Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.

scientific article published in March 2002

Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1006/VIRO.2001.1326
P698PubMed publication ID12009874
P5875ResearchGate publication ID11361316

P50authorJohn D. LambrisQ6228220
Roselyn J. EisenbergQ20675664
Gary H CohenQ88784699
Harvey M. FriedmanQ89912954
P2093author name stringAnn H Rux
Huan Lou
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectheparinQ190016
P304page(s)324-332
P577publication date2002-03-01
P1433published inVirologyQ7934867
P1476titleKinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
P478volume294

Reverse relations

cites work (P2860)
Q35914367A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens
Q34141544Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread
Q83874921Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages
Q42664630Characterization of the gene encoding glycoprotein C of duck enteritis virus
Q90126817Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes
Q33804431Complement Evasion Strategies of Viruses: An Overview
Q36878921Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells
Q33623972Complement evasion by human pathogens
Q39594070Detection of anatid herpesvirus 1 gC gene by TaqMan fluorescent quantitative real-time PCR with specific primers and probe
Q45710613Direct Binding of Herpes Simplex Virus Type 1 Virions to Complement C3
Q34593833Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans
Q90560370Drivers and regulators of humoral innate immune responses to infection and cancer
Q35105400Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles
Q35182202Function of herpes simplex virus type 1 gD mutants with different receptor-binding affinities in virus entry and fusion
Q33788855Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1.
Q36925941HSV-1 exploits the innate immune scavenger receptor MARCO to enhance epithelial adsorption and infection.
Q40581107HSV-1 virions engineered for specific binding to cell surface receptors
Q33987520Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry
Q34545821Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.
Q34345831Herpes simplex virus type 1 evades the effects of antibody and complement in vivo
Q41873760Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding
Q37967568Human cytomegalovirus infection and atherothrombosis
Q45453302Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains
Q33910764In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection.
Q43678006Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance
Q33857937Mathematical modeling of herpes simplex virus distribution in solid tumors: implications for cancer gene therapy
Q38854789Mucin-like Region of Herpes Simplex Virus Type 1 Attachment Protein Glycoprotein C (gC) Modulates the Virus-Glycosaminoglycan Interaction
Q57016583Multivalent binding of herpesvirus to living cells is tightly regulated during infection
Q35973512Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific
Q37547107Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs
Q42805655Quantitative comparison of the HSV-1 and HSV-2 transcriptomes using DNA microarray analysis.
Q37415391Regulation of HSV glycoprotein induced cascade of events governing cell-cell fusion
Q24683262Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry
Q24538731Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM).
Q33610941The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.
Q27488704Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans
Q38995165Viral-derived complement inhibitors: current status and potential role in immunomodulation

Search more.